InsiderTrades

Form 4 for ELAN Elanco Animal Health Inc

Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001415889-24-006644 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-05 2024-03-01 ELAN McArdle Grace EVP, MANUFACTURING AND QUALITY F - Tax $16.03 -1,921 54.9K -3% -$30.8K
D 2024-03-05 2024-03-01 ELAN McArdle Grace EVP, MANUFACTURING AND QUALITY A - Grant $0.00 +14.2K 56.8K +33% $0
D 2024-03-05 2024-03-01 ELAN McArdle Grace EVP, MANUFACTURING AND QUALITY A - Grant $0.00 +31.0K 31.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-01 F D 1,921 $16.03 54,908 D — — (F2) Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
2 Common Common Stock 2024-03-01 A A 14,193 $0.00 56,829 D — — (F1) Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.
3 Derivative Employee Stock Option(right to buy) 2024-03-01 A A 30,953 $0.00 30,953 D $16.03 · — to 2034-03-01 30,953 Common Stock (F3) Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.